Stock SAC SANOCHEMIA PHARMAZEUTIKA AG
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News SANOCHEMIA Pharmazeutika AG

Equities

SAC

AT0000776307

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
EOSS Technology GmbH, Wirtschaft Burgenland GmbH – WiBuG and b·e·imaging·GmbH acquired SANOCHEMIA Pharmazeutika AG from bew Beteiligungs GmbH and other shareholders.
CI
SANOCHEMIA Pharmazeutika AG announced that it has received €6 million in funding from bew Beteiligungs GmbH
CI
Bew Beteiligungs GmbH acquired an unknown stake in SANOCHEMIA Pharmazeutika AG from Inphasearch AG.
CI
SANOCHEMIA Pharmazeutika AG announced that it expects to receive €6 million in funding from bew Beteiligungs GmbH
CI
SANOCHEMIA Pharmazeutika : PTA-Adhoc Sanochemia Pharmazeutika AG aims for plan insolvency
PU
SANOCHEMIA Pharmazeutika AG Announces Positive Topline Results from Phase 2 Star Study of Tolperisone in Acute Muscle Spasms of the Back in the U.S
CI
Sanochemia Pharmazeutika Ag Names Timo Bender as CEO, Effective February 1, 2019
CI
B·e·imaging·GmbH acquired 14.5% stake in SANOCHEMIA Pharmazeutika AG from Inphasearch AG.
CI
SANOCHEMIA Pharmazeutika AG Announces Board Changes
CI
Sanochemia Pharmazeutika Ag Reports Earnings Results for the Six Months of the Year 2018
CI
Sanochemia Pharmazeutika AG Announces Sales Results for the First Quarter of Fiscal 2017; Provides Earnings Guidance for the Full Year of Fiscal 2017
CI
Invesa AG and Inphasearch AG cancelled the acquisition of 34.9% stake in Sanochemia Pharmazeutika AG from Sanochemia Ltd.
CI
Sanochemia Announces Earnings Results for the Full Year of Fiscal 2016
CI
Invesa AG and Inphasearch AG agreed to acquire 34.9% stake in Sanochemia Pharmazeutika AG from Sanochemia Ltd.
CI
Sanochemia Extends Contracts with Janssen N.V
CI
Sanochemia Reports Preliminary Earnings Results for the Fiscal Year 2013
CI
Link Healthcare Obtains Extensive Regional Rights to Secrelux from Sanochemia Pharmazeutika AG
CI
Sanochemia Pharmazeutika AG's Equity Buyback has expired
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SAC Stock
  4. News SANOCHEMIA Pharmazeutika AG
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW